(Q34573602)

3 August 2017

0 references

Proton pump inhibitor therapy for suspected GERD-related chronic laryngitis: a meta-analysis of randomized controlled trials (English)

1 reference

3 August 2017

0 references

1 reference

5

J Pieter Noordzij

1 reference

3 August 2017

Mohammed A Qadeer

1

1 reference

3 August 2017

Christopher O Phillips

2

1 reference

3 August 2017

A Rocio Lopez

3

1 reference

3 August 2017

David L Steward

4

1 reference

3 August 2017

John M Wo

6

1 reference

3 August 2017

Maria Suurna

7

1 reference

3 August 2017

Thomas Havas

8

1 reference

3 August 2017

Colin W Howden

9

1 reference

3 August 2017

Michael F Vaezi

10

1 reference

3 August 2017

language of work or name

English

0 references

publication date

13 October 2006

1 reference

The American Journal of Gastroenterology

3 August 2017

published in

1 reference

3 August 2017

volume

101

1 reference

3 August 2017

issue

11

1 reference

3 August 2017

page(s)

2646-2654

1 reference

Diagnosis and management of chronic laryngitis associated with reflux

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00844.X

Laryngeal signs and symptoms and gastroesophageal reflux disease (GERD): a critical assessment of cause and effect association

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00844.X

Effectiveness of proton pump inhibitors in nonerosive reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00844.X

Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00844.X

Outcomes of acid suppressive therapy in patients with posterior laryngitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00844.X

Association of laryngopharyngeal symptoms with gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00844.X

Treatment of chronic posterior laryngitis with esomeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00844.X

Proton pump inhibitor therapy for chronic laryngo-pharyngitis: a randomized placebo-control trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00844.X

Effect of pantoprazole on the course of reflux-associated laryngitis: a placebo-controlled double-blind crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00844.X

Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00844.X

Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00844.X

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00844.X

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00844.X

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00844.X

A sensitivity analysis for publication bias in systematic reviews.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00844.X

Therapy Insight: gastroesophageal reflux disease and laryngopharyngeal reflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00844.X

Ear, nose and throat and respiratory manifestations of gastro-esophageal reflux disease: an increasing conundrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00844.X

Review article: extraoesophageal manifestations of gastro-oesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00844.X

Empiric esomeprazole in the treatment of laryngopharyngeal reflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00844.X

Sensitivity and specificity of reflux-attributed laryngeal lesions: experimental and clinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00844.X

The prevalence of hypopharynx findings associated with gastroesophageal reflux in normal volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00844.X

Correlation of pH probe-measured laryngopharyngeal reflux with symptoms and signs of reflux laryngitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00844.X

The placebo effect in irritable bowel syndrome trials: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00844.X

Does the inclusion of grey literature influence estimates of intervention effectiveness reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00844.X

10.1111/J.1572-0241.2006.00844.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference